Visualization and Structured Attention Behaviour for Pain and Anxiety Reduction During Ablation of Atrial Fibrillation
1 other identifier
interventional
140
1 country
1
Brief Summary
The purpose of this study is to test the efficacy of visualization and relaxation exercises together with a structured behavioural attention from nurses during ablation of atrial fibrillation. The study will test the following hypothesis which is also aim for intervention: Relaxation and visualization performed in patients during ablation of atrial fibrillation combined with structured attention behaviour from the nurse reduces the patient's experience of pain and anxiety - and secondary reduces the consumption of painkillers and the number of episodes of adverse outcome that requires extra attention from staff. The survey is conducted as a controlled trial with a control group and an intervention group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable atrial-fibrillation
Started Nov 2009
Shorter than P25 for not_applicable atrial-fibrillation
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2009
CompletedFirst Submitted
Initial submission to the registry
July 8, 2010
CompletedFirst Posted
Study publicly available on registry
July 15, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2011
CompletedJuly 21, 2011
November 1, 2009
1.7 years
July 8, 2010
July 20, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain and anxiety is determined from self-reporting by the patient on a validated NRS scale.
Day 1 :Patient self-reporting every 15 minutes from the onset of the ablation procedure to the end of the ablation procedure. In addition self-reporting is recorded if the patient complains in between these fixed measurement points. No follow-up.
Secondary Outcomes (2)
Amount of Medication used /kg (Fentanyl and Midazolam) during the ablation procedure)
Day 1: From the onset to the end of the ablation procedure. No follow-up.
Number of adverse events during the ablation procedure
Day 1: Are recorded whenever they occur from the onset, to the end of the ablation procedure. No follow-up.
Study Arms (2)
Control group
NO INTERVENTIONThe control group receives conventional care and treatment
Intervention group
EXPERIMENTALthe intervention group receives visualization and relaxation exercises together with structured behavioural attention
Interventions
visualization and relaxation exercises together with structured behavioural attention.
Eligibility Criteria
You may qualify if:
- Patients referred for ablation of atrial fibrillation
You may not qualify if:
- Unable to give informed consent
- Impaired mental function, psychosis, severe chronic obstructive pulmonary disease, intolerance towards midazolam or fentanyl
- Undergoing the ablation in general anaesthesia
- Unable to speak or understand danish
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Coepenhagen University Hospital, Rigshospitalet
Copenhagen, Copenhagen Ø, DK 2100, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Preben U Pedersen, RN, PhD
The Cardiac Cath.lab. The Heartcenter,Rigshospitalet, Copenhagen Denmark
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
July 8, 2010
First Posted
July 15, 2010
Study Start
November 1, 2009
Primary Completion
July 1, 2011
Study Completion
July 1, 2011
Last Updated
July 21, 2011
Record last verified: 2009-11